Toxicology News and Research RSS Feed - Toxicology News and Research

Toxicology is the study of harmful interactions between chemical, physical, or biological agents and biological systems.
Service to screen for DNA damaging compounds released by Merck

Service to screen for DNA damaging compounds released by Merck

Merck, a leading science and technology company, has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds. Offered through its BioReliance® testing facilities, Merck will be the first company to provide this service in the United States. [More]
Exposure to insecticides that mimic melatonin could put people at higher risk for diabetes

Exposure to insecticides that mimic melatonin could put people at higher risk for diabetes

Synthetic chemicals commonly found in insecticides and garden products bind to the receptors that govern our biological clocks, University at Buffalo researchers have found. [More]
Nanoparticle exposure can trigger dormant viruses in lung tissue cells

Nanoparticle exposure can trigger dormant viruses in lung tissue cells

Nanoparticles from combustion engines can activate viruses that are dormant in lung tissue cells. This is the result of a study by researchers of Helmholtz Zentrum München, a partner in the German Center for Lung Research, which has now been published in the journal 'Particle and Fibre Toxicology'. [More]
Study strengthens therapeutic potential for niacin-based diet in treatment of Parkinson's disease

Study strengthens therapeutic potential for niacin-based diet in treatment of Parkinson's disease

People with certain forms of early-onset Parkinson's disease may benefit from boosting the amount of niacin in their diet, according to new research from the University of Leicester. [More]
Researchers reveal how inflammatory responses block fat cell conversion

Researchers reveal how inflammatory responses block fat cell conversion

Scientists at the University of Bonn have shown in mice that excess pounds can simply be melted away by converting unwanted white fat cells into energy-consuming brown slimming cells. [More]
Alere provides update on CMS decision to revoke Medicare billing privileges of Arriva Medical

Alere provides update on CMS decision to revoke Medicare billing privileges of Arriva Medical

Alere Inc., a global leader in rapid diagnostic tests, today provided an update on the decision by the Centers for Medicare & Medicaid Services (CMS) to revoke Arriva Medical's Medicare billing privileges. [More]
Scientists identify potential drug treatment in fight against Alzheimer’s disease

Scientists identify potential drug treatment in fight against Alzheimer’s disease

An international team of scientists has announced a new advance in the fight against Alzheimer’s disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice. [More]

UL Environment experts to serve as advisory board member of Johns Hopkins Center for Alternatives to Animal Testing

UL (Underwriters Laboratories), a global safety science leader, announced today that UL Environment’s Craig Rowlands, PhD, DABT, senior toxicologist, will serve as an advisory board member of Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and UL Environment’s Anne Bonhoff, PhD, global head of chemistry, will serve as an advisory board member of the European branch (CAAT-Europe) located at the University of Konstanz, Germany. [More]
Lab-based cellular tests reveal that e-cigarette vapour does not induce DNA damage

Lab-based cellular tests reveal that e-cigarette vapour does not induce DNA damage

E-cigarette vapour does not damage DNA, even at doses 28 times that of equivalent smoke exposure. [More]
Study reveals self-harm is leading cause of pregnancy-related deaths in Colorado

Study reveals self-harm is leading cause of pregnancy-related deaths in Colorado

Self-harm was the leading cause of pregnancy-associated deaths in Colorado from 2004 to 2014, ahead of car crashes, medical conditions and homicide, according to researchers at the University of Colorado Anschutz Medical Campus. [More]

UL collaborates with renowned researchers to develop new tool that predicts chemical toxicity of substances

UL (Underwriters Laboratories), a global safety science company, announced today it is entering into a relationship with world-renown toxicologists and researchers to develop a cutting-edge tool to predict the toxicity of chemicals. [More]
Metabolomics research at the Phenome Centre Birmingham

Metabolomics research at the Phenome Centre Birmingham

The new Phenome Centre Birmingham is an eight-million-pound research facility that has been funded by the Medical Research Council, by the University of Birmingham, and by four industry partners, namely, Beckman Coulter, Bruker, ThermoFisher Scientific and Waters. It is a clinical phenotyping centre. [More]
ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

The University of Utah College of Pharmacy's Anticonvulsant Drug Development Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health to test drugs to treat epilepsy, and the major focus of the project is to address needs that affect millions of people worldwide -identify novel investigational compounds to prevent the development of epilepsy or to treat refractory, or drug-resistant, epilepsy. [More]
New technique for identifying illicit drugs can provide high sensitivity and rapid results

New technique for identifying illicit drugs can provide high sensitivity and rapid results

For the identification of illicit drugs in forensic toxicological casework, analysis can be delayed and potentially compromised due to lengthy sample preparation. However a new technique has been developed that can provide high sensitivity and fast results. [More]
Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Amgen and Allergan plc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 215, a biosimilar candidate to Avastin (bevacizumab). [More]
Exposure to licorice compound disrupts steroid sex hormone production in ovary

Exposure to licorice compound disrupts steroid sex hormone production in ovary

A study of mouse reproductive tissues finds that exposure to isoliquiritigenin, a compound found in licorice, disrupts steroid sex hormone production in the ovary, researchers report. [More]
E-cigarette vapour does not induce DNA mutations linked to tobacco smoke exposures

E-cigarette vapour does not induce DNA mutations linked to tobacco smoke exposures

E-cigarette vapour does not induce DNA mutations commonly observed with tobacco smoke exposures in lab-based tests. [More]
Advances in POC diabetes testing: an interview with Gavin Jones

Advances in POC diabetes testing: an interview with Gavin Jones

Glycated hemoglobin (HbA1c) is well recognized as a reliable measure for glycemic control. The role of HbA1c testing in the management of patients with diabetes has been well established for several decades. HbA1c levels reflect the average circulating glucose concentration over the lifespan of... [More]
Study finds increasing incidence of hospitalizations for prescription opioid poisonings in children and teens

Study finds increasing incidence of hospitalizations for prescription opioid poisonings in children and teens

The overall incidence of hospitalizations for prescription opioid poisonings in children and adolescents has more than doubled from 1997 to 2012, with increasing incidence of poisonings attributed to suicide or self-inflicted injury and accidental intent, according to a new study published online by JAMA Pediatrics. [More]
Nano-biointeraction and nanopathology

Nano-biointeraction and nanopathology

Nanoparticles enter the organism in a number of ways. In most cases through inhalation and ingestion. When inhaled, the majority of them are expelled with the next breath. When ingested, most of them are gotten rid of through feces. [More]
Advertisement
Advertisement